Caravella McCuistian, PhD, MA

Title(s)Assistant Professor, Psychiatry
SchoolSchool of Medicine
Address1001 Potrero Avenue, #7G15
San Francisco CA 94110
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Caravella McCuistian PhD is a Clinical Psychologist and Assistant Professor at the University of California, San Francisco. Her research interests include addressing health disparities among underserved populations including substance-using populations, racial/ethnic minorities, women, and individuals living with HIV. She has conducted research that utilizes community-engaged methodology, including community-based participatory research, to develop behavioral interventions to improve health, including the development of culturally informed HIV prevention interventions for women who use substances as well as women engaged in transactional sex. Dr. McCuistian is also interested in addressing health disparities in novel ways such as integrating health interventions into substance use residential treatment facilities as well as leveraging technology to provide interventions to underserved communities.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Reducing tobacco use in substance use treatment: The California tobacco free initiative. Addict Behav. 2024 Mar 30; 155:108025. McCuistian C, Lisha NE, Campbell B, Cheng C, Le J, Guydish J. PMID: 38593596.
      View in: PubMed   Mentions:
    2. Policy and Practice Changes Associated with a Tobacco-Free Initiative in Residential Substance Use Disorder Treatment. J Psychoactive Drugs. 2024 Feb 16; 1-10. Campbell BK, Le T, McCuistian C, Bonniot C, Delucchi K, Guydish J. PMID: 38363096.
      View in: PubMed   Mentions:    Fields:    
    3. Culturally adapted safer sex skills building: development and initial testing of an HIV prevention intervention for Black women using substances in the United States. Health Educ Res. 2023 Dec 11; 38(6):527-536. Burlew AK, McCuistian C, Lanaway D. PMID: 37791870.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    4. iVY: protocol for a randomised clinical trial to test the effect of a technology-based intervention to improve virological suppression among young adults with HIV in the USA. BMJ Open. 2023 10 06; 13(10):e077676. Saberi P, Stoner MCD, McCuistian CL, Balaban C, Ming K, Wagner D, Chakraborty B, Smith L, Sukhija-Cohen A, Neilands TB, Gruber VA, Johnson MO. PMID: 37802624; PMCID: PMC10565330.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    5. Integrative data analysis of clinical trials network studies to examine the impact of psychosocial treatments for black people who use cocaine: Study protocol. Contemp Clin Trials. 2023 Oct; 133:107329. Haeny AM, McCuistian C, Burlew AK, Ruglass LM, Espinosa A, Jordan A, Roundtree C, Lopez J, Morgan-López AA. PMID: 37652354; PMCID: PMC10635737.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Editorial: Special issue on racism, racial identity, and substance use. J Subst Use Addict Treat. 2023 10; 153:209132. Montgomery L, Burlew K, McCuistian C. PMID: 37558182.
      View in: PubMed   Mentions: Translation:Humans
    7. A cluster-randomized trial of a brief multi-component intervention to improve tobacco outcomes in substance use treatment. Subst Abuse Treat Prev Policy. 2023 06 16; 18(1):34. Guydish J, McCuistian C, Hosakote S, Le T, Masson CL, Campbell BK, Delucchi K. PMID: 37328775; PMCID: PMC10276468.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Corrigendum: Comparing client and staff reports on tobacco-related knowledge, attitudes, beliefs and services provided in substance use treatment. Tob Induc Dis. 2023; 21:59. Martínez C, Lisha N, McCuistian C, Straus E, Delucchi K, Guydish J. PMID: 37181461; PMCID: PMC10174079.
      View in: PubMed   Mentions:
    9. Addressing nutrition and physical activity in substance use disorder treatment: Client reports from a wellness-oriented, tobacco-free policy intervention. Drug Alcohol Depend Rep. 2023 Jun; 7:100165. Campbell BK, Le T, Pagano A, McCuistian C, Woodward-Lopez G, Bonniot C, Guydish J. PMID: 37234703; PMCID: PMC10206429.
      View in: PubMed   Mentions:
    10. Comparing client and staff reports on tobacco-related knowledge, attitudes, beliefs and services provided in substance use treatment. Tob Induc Dis. 2023; 21:45. Martínez C, Lisha N, McCuistian C, Strauss E, Deluchi K, Guydish J. PMID: 36969981; PMCID: PMC10037428.
      View in: PubMed   Mentions:
    11. Cultural and Psychosocial Correlates of co-use among Black-White Biracial Adults. J Subst Use Addict Treat. 2023 10; 153:209006. Miller-Roenigk B, Peteet B, McCuistian C, Burlew AK. PMID: 36931606; PMCID: PMC10502184.
      View in: PubMed   Mentions: Translation:Humans
    12. Ethical Dilemmas Facing Substance Use Counselors During the COVID-19 Pandemic. Subst Abuse. 2023; 17:11782218231158338. McCuistian C, Fokuo JK, Dumoit Smith J, Sorensen JL, Arnold EA. PMID: 36923068; PMCID: PMC10008725.
      View in: PubMed   Mentions:
    13. Smoking Behavior and Wellness among Individuals in Substance Use Disorder Treatment. J Psychoactive Drugs. 2023 Jul-Aug; 55(3):330-341. Pagano A, McCuistian C, Le T, Campbell BK, Delucchi K, Woodward-Lopez G, Guydish J. PMID: 35815722; PMCID: PMC9826798.
      View in: PubMed   Mentions:    Fields:    
    14. Pre-implementation Assessment of Tobacco Cessation Interventions in Substance Use Disorder Residential Programs in California. Subst Use Misuse. 2022; 57(9):1345-1355. Fokuo JK, McCuistian CL, Masson CL, Gruber VA, Straus E, Wong J, Guydish JR. PMID: 35621319; PMCID: PMC10083040.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    15. Consideration of racism experiences in the implementation of trauma-focused therapy in primary care. Health Serv Res. 2022 12; 57 Suppl 2:235-248. McCuistian C, Kimball SL, Buitron de la Vega P, Godfrey LB, Fortuna LR, Valentine SE. PMID: 35521941; PMCID: PMC9660427.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    16. Implementing tobacco-free policy in residential substance use disorders treatment: Practice changes among staff. Drug Alcohol Depend Rep. 2022 Mar; 2:100033. Campbell BK, Le T, McCuistian C, Hosakote S, Kapiteni K, Guydish J. PMID: 36845887; PMCID: PMC9948912.
      View in: PubMed   Mentions: 4  
    17. Advancing Health Equity through Substance Use Research. J Psychoactive Drugs. 2021 Nov-Dec; 53(5):379-383. McCuistian C, Burlew K, Espinosa A, Ruglass LM, Sorrell T. PMID: 34706637; PMCID: PMC8692385.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    18. Reducing tobacco use in substance use treatment: An intervention to promote tobacco-free grounds. J Subst Abuse Treat. 2022 04; 135:108640. McCuistian C, Kapiteni K, Le T, Safier J, Delucchi K, Guydish J. PMID: 34743925; PMCID: PMC8903046.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsPHPublic Health
    19. Racial/Ethnic Differences in Tobacco Use and Cessation Services among Individuals in Substance Use Treatment. J Psychoactive Drugs. 2021 Nov-Dec; 53(5):483-490. McCuistian C, Le T, Delucchi K, Pagano A, Hosakote S, Guydish J. PMID: 34672862; PMCID: PMC8959398.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. Ethnic Identity, Perceived Discrimination, Substance Use and Misuse among Black-White Biracial Adults. Subst Use Misuse. 2021; 56(14):2151-2159. Miller-Roenigk B, Peteet B, McCuistian C, Kathleen Burlew A. PMID: 34499585; PMCID: PMC8796318.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    21. Racial/ethnic equity in substance use treatment research: the way forward. Addict Sci Clin Pract. 2021 08 05; 16(1):50. Burlew K, McCuistian C, Szapocznik J. PMID: 34353373; PMCID: PMC8340520.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    22. COVID-19 vaccine trust among clients in a sample of California residential substance use treatment programs. Drug Alcohol Depend. 2021 08 01; 225:108812. Masson CL, McCuistian C, Straus E, Elahi S, Chen M, Gruber VA, Le T, Guydish J. PMID: 34174773; PMCID: PMC8221747.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    23. Sexual Health Interventions for Racial/Ethnic Minorities Using Community-Based Participatory Research: A Systematic Review. Health Educ Behav. 2023 Feb; 50(1):107-120. McCuistian C, Peteet B, Burlew K, Jacquez F. PMID: 33870765; PMCID: PMC9004606.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    24. Addressing HIV care, mental health and substance use among youth and young adults in the Bay Area: description of an intervention to improve information, motivation and behavioural skills. BMJ Open. 2021 Apr 08; 11(4):e042713. McCuistian C, Wootton AR, Legnitto-Packard D, Gruber VA, Dawson-Rose C, Johnson MO, Saberi P. PMID: 38058024; PMCID: PMC8039246.
      View in: PubMed   Mentions:    Fields:    
    25. Video-Counseling Intervention to Address HIV Care Engagement, Mental Health, and Substance Use Challenges: A Pilot Randomized Clinical Trial for Youth and Young Adults Living with HIV. Telemed Rep. 2021; 2(1):14-25. Saberi P, McCuistian C, Agnew E, Wootton AR, Legnitto Packard DA, Dawson-Rose C, Johnson MO, Gruber VA, Neilands TB. PMID: 33575683; PMCID: PMC7869821.
      View in: PubMed   Mentions: 7  
    26. One size does not fit all: A NIDA CTN inspired model for community engaged cultural adaptation. J Subst Abuse Treat. 2020 03; 112S:28-33. Burlew AK, McCuistian C, Lanaway D, Hatch-Maillette M, Shambley-Ebron D. PMID: 32220407; PMCID: PMC8784174.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    27. Overcoming Technological Challenges: Lessons Learned from a Telehealth Counseling Study. Telemed J E Health. 2020 10; 26(10):1278-1283. Wootton AR, McCuistian C, Legnitto Packard DA, Gruber VA, Saberi P. PMID: 31800368.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    28. Best practices for researching diverse groups. Am J Orthopsychiatry. 2019; 89(3):354-368. Burlew AK, Peteet BJ, McCuistian C, Miller-Roenigk BD. PMID: 31070421.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    29. Transnational trends in prescription drug misuse among women: A systematic review. Int J Drug Policy. 2019 01; 63:56-73. Peteet B, Mosley C, Miller-Roenigk B, McCuistian C, Dixon S. PMID: 30500475.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    Caravella's Networks
    Concepts (60)
    Derived automatically from this person's publications.
    Co-Authors (13)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department